← Back to Clinical Trials
Recruiting NCT07579130

NCT07579130 Comparative Assessment of Lipid Layer Thickness Measurements

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07579130
Status Recruiting
Phase
Sponsor Indiana University
Condition Dry Eye
Study Type OBSERVATIONAL
Enrollment 50 participants
Start Date 2026-04-01
Primary Completion 2028-12-20

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 100 Years
Study Type OBSERVATIONAL
Interventions
LipiViewOmnicadBruder Ocular Surface Analyzer

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 50 participants in total. It began in 2026-04-01 with a primary completion date of 2028-12-20.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study compares ocular lipid layer thickness (LLT) measurements obtained from three commonly used clinical diagnostic devices to evaluate their agreement and consistency. It further examines which device's LLT measurements show the strongest correlation with established clinical indicators of dry eye disease severity.

Eligibility Criteria

Inclusion Criteria: * Dry eye disease Exclusion Criteria: * None

Contact & Investigator

Central Contact

Anna Tichenor

✉ annatich@iu.edu

📞 8128550520

Frequently Asked Questions

Who can join the NCT07579130 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Dry Eye. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07579130 currently recruiting?

Yes, NCT07579130 is actively recruiting participants. Contact the research team at annatich@iu.edu for enrollment information.

Where is the NCT07579130 trial being conducted?

This trial is being conducted at Bloomington, United States.

Who is sponsoring the NCT07579130 clinical trial?

NCT07579130 is sponsored by Indiana University. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology